Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ageas/ NV's change in receivables for the quarter that ended in Dec. 2025 was $0 Mil. It means Ageas/ NV's Accounts Receivable
stayed the same
from Jun. 2025 to Dec. 2025 .
Ageas/ NV's change in receivables for the fiscal year that ended in Dec. 2025 was $0 Mil. It means Ageas/ NV's Accounts Receivable
stayed the same
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Ageas/ NV's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 0.00.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ageas/ NV's liquidation value for the
six
months ended in Dec. 2025 was $-39,008 Mil.
Ageas/ NV (OTCPK:AGESF) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Ageas/ NV's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ageas/ NV Change In Receivables Related Terms
Ageas/ NV Change In Receivables Historical Data
* Premium members only.
The historical data trend for Ageas/ NV's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ageas/ NV (AGESF) has a Change In Receivables of $0 Mil as of Dec. 2025. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ageas/ NV and its competitors.
Is Ageas/ NV's Change In Receivables too high?
Ageas/ NV's current Change In Receivables is $0 Mil. Overall, Ageas/ NV has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ageas/ NV's Change In Receivables compare to BRK.A and AIG?
Ageas/ NV's Change In Receivables of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for an Insurance company?
A good Change In Receivables depends on the Insurance industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ageas/ NV and its competitors. Ageas/ NV's current Change In Receivables is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ageas/ NV stock overvalued right now?
Based on GuruFocus' analysis, Ageas/ NV (AGESF) is currently considered Modestly Overvalued. The stock's GF Value™ is $66.58, compared to a current price of $79.04 — trading 18.7% above its estimated fair value. The current Change In Receivables is $0 Mil. Ageas/ NV's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Ageas/ NV (AGESF), the current Change In Receivables is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ageas/ NV (AGESF) Overvalued in 2026?
Based on GuruFocus' analysis, Ageas/ NV stock appears to be overvalued.
The current stock price of $79.04 is trading 18.7% above its estimated GF Value™ of $66.58.
GuruFocus considers Ageas/ NV to be Modestly Overvalued.
Key valuation signals for AGESF:
Change In Receivables: $0 Mil
GF Value™: $66.58 vs. price of $79.04 (18.7% above fair value)
No single metric tells the full story. See the AGESF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ageas was spun out of Fortis during the financial crisis after a consortium including Banco Santander and Royal Bank of Scotland launched a failed bid for ABN Amro. The takeover was badly timed and overly ambitious, and to fund it Fortis started selling noncore divisions while writing down collateralized debt. As Fortis' capital began to decline, the company initiated a rights issue, and suspended the dividend. As Fortis' share price began to decline and financial market conditions continued to deteriorate, with a series of leadership changes, customers began to withdraw deposits. Fortis was approached by the government and sold its domestic banking operations to the Belgian government. It also spun off its asset management and insurance units which later became Ageas.
65GF Score
Get the complete analysis for AGESF
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGESF has been successfully added to your 
